Rev Fall News Pages copy.qxd

First Page		Document Content
Date: 2013-09-19 18:47:52 Triazines Myelodysplastic syndrome Syndromes Myeloid leukemia Lenalidomide Decitabine Acute myeloid leukemia International Prognostic Scoring System Azacitidine Medicine Oncology Nucleosides		Rev Fall News Pages copy.qxd Add to Reading List Source URL: www.mds-foundation.org Download Document from Source Website File Size: 1,86 MB Share Document on Facebook

	GLAL_A_375719 ++ DocID: 19fUF - View Document
	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer DocID: 103lx - View Document
	PBAC STAKEHOLDER MEETING OUTCOME STATEMENT RUXOLITINIB FOR MYELOFIBROSIS 22 September 2014 The Sheraton Hotel, Melbourne Attendees Members of the Pharmaceutical Benefits Advisory Committee (PBAC), the consumer representa DocID: ZuUz - View Document
	Microsoft PowerPoint - LLS1104 - MDS slides - on background v14 (for pdf) [Compatibility Mode] DocID: YwaP - View Document
$Syndromes / Acute leukemia / Refractory cytopenia with multilineage dysplasia / Acute myeloid leukemia / Auer rod / Erythroid dysplasia / Sideroblastic anemia / Myeloproliferative disease / International Prognostic Scoring System / Medicine / Myeloid leukemia / Myelodysplastic syndrome$	Table 16.1 The World Health Organization[removed]classification of myelodysplasia. Subtype Peripheral blood DocID: XbLN - View Document